TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents화, 05/08/2014 - 15:09
The fear of using topical corticosteroids, usually called topical corticophobia, is a frequent concern for atopic dermatitis patients and/or their parents. Assessing patients’ atopic dermatitis and their parents’ topical corticosteroid phobia is an essential step to improving adherence to treatment. Because topical corticophobia appears to be a complex phenomenon, its evaluation by binary responses (yes/no) is too simplistic. Thus, a scale is needed, which is capable of identifying the subtleties of topical corticosteroid phobia.
Knockdown of Filaggrin in a Three-Dimensional Reconstructed Human Epidermis Impairs Keratinocyte Differentiation금, 03/04/2015 - 18:00
Valérie Pendaries, Jeremy Malaisse, Laurence Pellerin, Marina Le Lamer, Rachida Nachat, Sanja Kezic, Anne-Marie Schmitt, Carle Paul, Yves Poumay, Guy Serre and Michel Simon
By Dr. Daniel Wallach
Atopic dermatitis is a complex illness that is closely related to two other conditions, allergic asthma and allergic rhinoconjunctivitis. The common factor between these three illnesses, which we call the atopic predisposition, is a predisposition to produce IgE-class antibodies directed against antigens present in the everyday environment. Therefore, a child with atopic dermatitis (eczema in early childhood) is more at risk than another child of going on to develop allergic rhinoconjunctivitis and asthma.
Cow’s milk protein allergies (CMPA) affect 2 to 3% of infants. They appear when weaning or when giving the first bottles of milk. The allergy causes cutaneous, digestive or more rarely respiratory symptoms. Their onset depends on the underlying immunopathological mechanism, which makes a didactic classification and practical exploration of the allergic reactions possible.
*Dr. J. Robert - Pediatrician - Atopic Dermatitis Therapeutic Education Consultation - Lyon Sud Hospital Center - Pavillon Dufour - 69495 Pierre Bénite Cedex